141 related articles for article (PubMed ID: 24938709)
1. Development of anti-adhesive spongy sheet composed of hyaluronic acid and collagen containing epidermal growth factor.
Kuroyanagi M; Yamamoto A; Shimizu N; Toi A; Inomata T; Takeda A; Kuroyanagi Y
J Biomater Sci Polym Ed; 2014; 25(12):1253-65. PubMed ID: 24938709
[TBL] [Abstract][Full Text] [Related]
2. Development of a wound dressing composed of hyaluronic acid and collagen sponge with epidermal growth factor.
Kondo S; Kuroyanagi Y
J Biomater Sci Polym Ed; 2012; 23(5):629-43. PubMed ID: 21375805
[TBL] [Abstract][Full Text] [Related]
3. Development of cultured dermal substitute composed of hyaluronic acid and collagen spongy sheet containing fibroblasts and epidermal growth factor.
Kuroyanagi M; Yamamoto A; Shimizu N; Ishihara E; Ohno H; Takeda A; Kuroyanagi Y
J Biomater Sci Polym Ed; 2014; 25(11):1133-43. PubMed ID: 24890602
[TBL] [Abstract][Full Text] [Related]
4. Development of a wound dressing composed of hyaluronic acid sponge containing arginine and epidermal growth factor.
Matsumoto Y; Kuroyanagi Y
J Biomater Sci Polym Ed; 2010; 21(6-7):715-26. PubMed ID: 20482980
[TBL] [Abstract][Full Text] [Related]
5. Development of an artificial dermis composed of hyaluronic acid and collagen.
Mineo A; Suzuki R; Kuroyanagi Y
J Biomater Sci Polym Ed; 2013; 24(6):726-40. PubMed ID: 23565912
[TBL] [Abstract][Full Text] [Related]
6. Wound dressing composed of hyaluronic acid and collagen containing EGF or bFGF: comparative culture study.
Yu A; Niiyama H; Kondo S; Yamamoto A; Suzuki R; Kuroyanagi Y
J Biomater Sci Polym Ed; 2013; 24(8):1015-26. PubMed ID: 23647255
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor in diabetic mice.
Kondo S; Niiyama H; Yu A; Kuroyanagi Y
J Biomater Sci Polym Ed; 2012; 23(13):1729-40. PubMed ID: 21943516
[TBL] [Abstract][Full Text] [Related]
8. Development of a functional wound dressing composed of hyaluronic acid spongy sheet containing bioactive components: evaluation of wound healing potential in animal tests.
Shimizu N; Ishida D; Yamamoto A; Kuroyanagi M; Kuroyanagi Y
J Biomater Sci Polym Ed; 2014; 25(12):1278-91. PubMed ID: 24959914
[TBL] [Abstract][Full Text] [Related]
9. Development of novel wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor and vitamin C derivative.
Niiyama H; Kuroyanagi Y
J Artif Organs; 2014 Mar; 17(1):81-7. PubMed ID: 24292853
[TBL] [Abstract][Full Text] [Related]
10. Potential of a cryopreserved cultured dermal substitute composed of hyaluronic acid and collagen to release angiogenic cytokine.
Sawa M; Kuroyanagi Y
J Biomater Sci Polym Ed; 2013; 24(2):224-38. PubMed ID: 23565599
[TBL] [Abstract][Full Text] [Related]
11. Development of a wound dressing composed of a hyaluronic acid sponge containing arginine.
Matsumoto Y; Arai K; Momose H; Kuroyanagi Y
J Biomater Sci Polym Ed; 2009; 20(7-8):993-1004. PubMed ID: 19454165
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts.
Kubo K; Kuroyanagi Y
J Artif Organs; 2003; 6(2):138-44. PubMed ID: 14598115
[TBL] [Abstract][Full Text] [Related]
13. Effect of EGF and bFGF on fibroblast proliferation and angiogenic cytokine production from cultured dermal substitutes.
Yu A; Matsuda Y; Takeda A; Uchinuma E; Kuroyanagi Y
J Biomater Sci Polym Ed; 2012; 23(10):1315-24. PubMed ID: 21722419
[TBL] [Abstract][Full Text] [Related]
14. Potential of wound dressing composed of hyaluronic acid containing epidermal growth factor to enhance cytokine production by fibroblasts.
Yamamoto A; Shimizu N; Kuroyanagi Y
J Artif Organs; 2013 Dec; 16(4):489-94. PubMed ID: 24013475
[TBL] [Abstract][Full Text] [Related]
15. Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test.
Kubo K; Kuroyanagi Y
J Artif Organs; 2003; 6(1):64-70. PubMed ID: 14598127
[TBL] [Abstract][Full Text] [Related]
16. Topical high-molecular-weight hyaluronan and a roofing barrier sheet equally inhibit postlaminectomy fibrosis.
Akeson WH; Massie JB; Huang B; Giurea A; Sah R; Garfin SR; Kim CW
Spine J; 2005; 5(2):180-90. PubMed ID: 15749618
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of emulsion electrospun polycaprolactone/hyaluronan/epidermal growth factor nanofibrous scaffolds for wound healing.
Wang Z; Qian Y; Li L; Pan L; Njunge LW; Dong L; Yang L
J Biomater Appl; 2016 Jan; 30(6):686-98. PubMed ID: 26012354
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antibiotic-loaded collagen-hyaluronic acid matrix as a skin substitute.
Park SN; Kim JK; Suh H
Biomaterials; 2004 Aug; 25(17):3689-98. PubMed ID: 15020144
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test.
Tanaka M; Nakakita N; Kuroyanagi Y
J Biomater Sci Polym Ed; 1999; 10(4):433-53. PubMed ID: 10227466
[TBL] [Abstract][Full Text] [Related]
20. A human epidermal growth factor-curcumin bandage bioconjugate loaded with mesenchymal stem cell for in vivo diabetic wound healing.
Mohanty C; Pradhan J
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110751. PubMed ID: 32279771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
